SCHEMBL1699243

SCHEMBL1699243

O=C(C=Cc1ccc2c(c1)OCO2)N(c1ccccn1)C1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 14/20 1.00
ALDH1A1 P00352 3/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
LMNA P02545 3/20 0.68
HTT P42858 1/20 0.67
KDM4E B2RXH2 3/20 0.67
POLB P06746 1/20 0.67
MAPT P10636 2/20 0.63
CACNA1B Q00975 1/20 0.63
APBA1 Q02410 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
MEN1 O00255 1/20 0.56
NPC1 O15118 1/20 0.56
PLIN1 O60240 1/20 0.56
PKM P14618 1/20 0.56
MAPK1 P28482 1/20 0.56
RAB9A P51151 1/20 0.56
PLIN5 Q00G26 1/20 0.56
KMT2A Q03164 1/20 0.56
ABHD5 Q8WTS1 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14822024 1.00 TRPM8 (1.00) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL30416175 1.00 TRPM8 (1.00) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL1699240 1.00 TRPM8 (1.00) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL30532217 1.00 TRPM8 (1.00) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL20772855 0.87 TRPM8 (0.76) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL29779963 0.87 TRPM8 (0.76) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL15276692 0.85 TRPM8 (0.75) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL15276695 0.85 TRPM8 (0.75) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL14822014 0.85 TRPM8 (0.73) TRPM8ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL15276725 0.85 TRPM8 (0.73) TRPM8ALDH1A1SMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392371-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2019-08-27 US claimed
EP-4725476-A2 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF Firmenich SA (CH) 2026-04-15 EP disclosed
EP-4096714-B1 COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF FIRMENICH & CIE (CH) 2026-01-28 EP disclosed
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT FIRMENICH INCORPORATED (US) 2025-12-25 US disclosed
EP-4608518-A1 ORAL CARE COMPOSITIONS Firmenich SA (CH) 2025-09-03 EP disclosed
EP-4251122-B1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT FIRMENICH INCORPORATED (US) 2025-03-12 EP disclosed
US-20250064063-A1 ANTIMICROBIAL COMPOSITION HAVING ENCAPSULATED COLORANT FIRMENICH SA (CH) 2025-02-27 US disclosed
EP-3663366-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2025-01-08 EP disclosed
US-20240307279-A1 FAST DRYING PERFUME COMPOSITION FIRMENICH SA (CH) 2024-09-19 US disclosed
US-20240285512-A1 ORAL CARE COMPOSITIONS FIRMENICH SA (CH) 2024-08-29 US disclosed
US-20170096418-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-04-06 US disclosed
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION SENOMYX INC (US) 2017-03-30 US disclosed
US-20160376263-A1 BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF SENOMYX INC (US) 2016-12-29 US disclosed
US-20150086491-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2015-03-26 US disclosed
US-8927605-B2 Use of physiological cooling active ingredients, and agents containing such active ingredients SYMRISE AG (DE) 2015-01-06 US disclosed
US-20130202543-A1 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT SYMRISE AG (DE) 2013-08-08 US disclosed
US-20120263659-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2012-10-18 US disclosed
EP-2501761-A2 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS Symrise AG (DE) 2012-09-26 EP disclosed
WO-2011061330-A9 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2012-01-05 WO disclosed
WO-2011061330-A2 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160376263-A1 BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF TAS2R5, TAS1R1, TAS2R1 TRPM8 70/4885ALDH1A1 1490/4885SMN1; SMN2 2390/4885
US-10392371-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM4, TRPM6 TRPM8 1/4885ALDH1A1 3726/4885SMN1; SMN2 2480/4885
US-20250387310-A1 COMPOSITIONS THAT ENHANCE THE COOLING EFFECT TAS2R30, TAS2R1, TAS2R20 TRPM8 165/4885ALDH1A1 540/4885SMN1; SMN2 651/4885
US-20150086491-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS TRPM8, TRPM7, TRPM2 TRPM8 1/4885ALDH1A1 2466/4885SMN1; SMN2 4426/4885
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION TRPA1, PDE6G, PDE6D TRPM8 97/4885ALDH1A1 1029/4885SMN1; SMN2 2225/4885
US-20130202543-A1 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT CUTA, MCOLN2, MCOLN3 TRPM8 10/4885ALDH1A1 1673/4885SMN1; SMN2 4076/4885
US-20170096418-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM6, TRPM4 TRPM8 1/4885ALDH1A1 3880/4885SMN1; SMN2 2345/4885
US-20120263659-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS TRPM8, TRPM7, TRPM2 TRPM8 1/4885ALDH1A1 2466/4885SMN1; SMN2 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.